Skip to main content

Table 2 Functional and biochemical markers of performance and recovery in absolute values. Values are expressed as mean, standard deviations (± SDs) and confidence intervals

From: Does photobiomodulation therapy combined to static magnetic field (PBMT-sMF) promote ergogenic effects even when the exercised muscle group is not irradiated? A randomized, triple-blind, placebo-controlled trial

Variable

Group

Baseline

Immediately after

1 h

24 h

48 h

72 h

MVC

(Nm)

Placebo

228.28 (± 30.27)

177.21 (± 27.33)

172.98 (± 29.38)

171.21 (± 29.40)

167.65 (± 29.80)

193.15 (± 29.95)

[209.52–247.04]

[160.27–194.14]

[154.77–191.19]

[152.99–189.43]

[149.18–186.12]

[174.59–211.71]

Local

231.72 (± 34.74)

213.54 (± 32.58)b

203.03 (± 30.23)b

213,74 (± 32.48)a,b

225.30 (± 29.45)a,b

249.59 (± 37.58)a,b

[210.19–253.25]

[193.35–233.73]

[184.29–221.77]

[193.61–233.87]

[207.05–243.55]

[226.30–272.88]

Non-local

213.11 (± 30.04)

171.93 (± 29.88)

155.63 (± 25.18)

164.56 (± 21.51)

181.08 (± 30.32)

178.74 (± 21.74)

[194.49–231.73]

[153.41–190.45]

[140.02–171.24]

[151.23–177.89]

[162.29–199.87]

[165.27–192.21]

CK

(U.L−1)

Placebo

43.87 (± 16.28)

43.31 (± 15.16)

58.51 (± 20.73)

162.31 (± 56.01)

234.97 (± 87.49)

233.60 (± 94.19)

[33.78–53.96]

[33.91–52.71]

[45.66–71.36]

[127.60–197.02]

[180.74–289.20]

[175.22–291.98]

Local

38.20 (± 11.29)

34.70 (± 12.83)

35.38 (± 15.34)

69.83 (± 30.35) a,b

74.80 (± 35.68)a,b

54.53 (± 28.85) a,b

[31.20–45.20]

[26.75–42.65]

[25.87–44.89]

[51.02–88.64]

[52.69–96.91]

[36.65–72.41]

Non-local

50.49 (± 12.89)

49.74 (± 15.09)

59.62 (± 16.02)

168.98 (± 61.69)

252.83 (± 118.01)

296.81 (± 88.28)

[42.50–58.48]

[40.39–59.09]

[49.69–69.55]

[130.74–207.22]

[179.69–325.97]

[242.09–351.53]

DOMS

(VAS - mm)

Placebo

0 (± 0)

13.10 (± 7.56)

37.40 (± 17.42)

49.70 (± 14.25)

52.30 (± 20.12)

50.60 (± 20.38)

[0–0]

[8.40–17.80]

[26.60–48.20]

[40.80–58.60]

[39.80–64.80]

[38.00–63.20]

Local

0 (± 0)

21.40 (± 14.17)

12.30 (± 14.28) a,b

16.60 (± 15.59) a,b

23.20 (± 17.83) a,b

20.40 (± 15.49) a,b

[0–0]

[12.60–30.30]

[3.40–21.20]

[6.90–26.30]

[12.20–34.20]

[10.80–30.00]

Non-local

0 (± 0)

21.70 (± 11.45)

42.40 (± 25.65)

54.50 (± 30.70)

65.90 (± 27.98)

57.20 (± 31.14)

[0–0]

[14.60–28.80]

[26.50–58.30]

[35.50–73.50]

[48.50–83.30]

[37.90–76.50]

Lactate

(mmol. L− 1)

Placebo

2.45 (± 0.83)

4.73 (± 1.47)

2.30 (± 0.84)

   

[1.94–2.96]

[3.82–5.64]

[1.78–2.82]

–

–

–

Local

2.56 (± 0.44)

3.35 (± 0.76) a,b

2.14 (± 0.33)

   

[2.29–2.83]

[2.88–3.82]

[1.94–2.34]

–

–

–

Non-local

2.06 (± 0.52)

4.62 (± 1.67)

2.31 (± 0.60)

   

[1.74–2.38]

[3.58–5.66]

[1.94–2.68]

–

–

–

  1. aDifferent compared to Placebo group (p < 0.05)
  2. bDifferent compared to Non-local group (p < 0.05)